Eli Lilly Lowers Zepbound Price, Boosts Accessibility

Eli Lilly reduces cash prices for Zepbound, its popular weight loss drug, by up to $150 per month on LillyDirect. This move follows Novo Nordisks price cuts for Wegovy and Ozempic, aiming to make these medications more accessible to patients paying out of pocket.The Daily News Now! — Every city. Every story. AI-powered. Hosted on Acast. See acast.com/privacy for more information.